尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Dalton Lisa, 董事. Insider active across 1 company, notably Nabriva Therapeutics plc. In total, 2 reports have been published. History available since 28 July 2021. The latest transaction was filed on 31 July 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Dalton Lisa is a Board Member of Nabriva Therapeutics plc. She plays a key role in overseeing the company's operations and strategies, bringing her expertise in the biotechnology field. Her contribution is crucial for the development and implementation of the company's initiatives.